Tuberculosis and Respiratory Diseases

Scope & Guideline

Uncovering breakthroughs in tuberculosis research.

Introduction

Immerse yourself in the scholarly insights of Tuberculosis and Respiratory Diseases with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1738-3536
PublisherTHE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 1980 to 2024
AbbreviationTUBERC RESPIR DIS / TUBERC. RESP. DIS.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address101-605, 58, Banpo-daero, Seocho-gu, SEOUL 06652, SOUTH KOREA

Aims and Scopes

The journal 'Tuberculosis and Respiratory Diseases' primarily focuses on advancing research and knowledge surrounding respiratory diseases, particularly tuberculosis and chronic obstructive pulmonary disease (COPD). It aims to publish high-quality research that enhances the understanding, diagnosis, treatment, and management of these conditions.
  1. Tuberculosis Research:
    The journal emphasizes studies related to tuberculosis, including epidemiology, treatment strategies, and the development of novel diagnostic methods, aiming to improve patient outcomes and public health responses.
  2. Chronic Obstructive Pulmonary Disease (COPD):
    Research on COPD is a core focus, covering various aspects such as pathophysiology, management strategies, exacerbation definitions, and the impact of comorbidities on patient health.
  3. Lung Cancer and Respiratory Neoplasms:
    The journal includes significant research on lung cancers, particularly non-small cell lung cancer, exploring treatment advancements, biomarkers for prognosis, and patient management.
  4. Infectious Respiratory Diseases:
    In addition to tuberculosis, the journal addresses other infectious respiratory diseases, including studies on viral infections like COVID-19, their clinical outcomes, and the impact on patients with pre-existing respiratory conditions.
  5. Pulmonary Rehabilitation and Patient Quality of Life:
    The journal publishes research on rehabilitation programs and interventions aimed at improving the quality of life for patients with chronic respiratory diseases, integrating psychological and social aspects.
  6. Environmental and Lifestyle Factors:
    Research on the effects of environmental factors, such as air pollution and smoking, on respiratory health is highlighted, recognizing their role in exacerbating conditions like COPD and asthma.
The journal has been actively adapting to new challenges and innovations in the field of respiratory diseases, leading to emerging themes that are gaining prominence. This section outlines these trending areas of focus.
  1. Impact of Digital Health Technologies:
    Recent publications highlight the integration of digital health solutions, such as telemedicine and mobile health applications, to improve medication adherence and patient management in respiratory diseases.
  2. Long-COVID and Post-Acute Sequelae:
    Research exploring the long-term effects of COVID-19 on respiratory health, including complications and management strategies, is increasingly significant, reflecting ongoing concerns about the pandemic's impact.
  3. Biomarkers and Personalized Medicine:
    There is a growing interest in identifying biomarkers for predicting disease progression and treatment response in tuberculosis and lung cancer, paving the way for personalized treatment approaches.
  4. Rehabilitation and Quality of Life Initiatives:
    Studies focusing on the rehabilitation of patients with chronic respiratory diseases and their quality of life are on the rise, emphasizing the holistic management of these conditions.
  5. Environmental Health and Respiratory Disease Interactions:
    Research on the interplay between environmental factors, such as air pollution, and respiratory diseases is becoming more prevalent, underscoring public health implications.

Declining or Waning

While certain themes remain prominent, others are showing signs of declining interest or fewer publications in recent years. This section identifies those waning scopes within the journal's focus.
  1. Traditional Tuberculosis Epidemiology Studies:
    There appears to be a shift away from basic epidemiological studies of tuberculosis towards more innovative research focusing on treatment and management strategies, as well as integration of technology.
  2. General Asthma Research:
    While asthma remains a topic of interest, the publication of studies focused solely on asthma without connections to COPD or other comorbidities is decreasing, indicating a trend towards integrated respiratory disease research.
  3. Historical Perspectives on Respiratory Diseases:
    Research that primarily revisits historical data or long-standing paradigms without introducing new insights or advancements is less frequently published, suggesting a preference for contemporary and innovative research.
  4. Pharmacological Studies on Older Medications:
    There is a noticeable decline in research focused on older medications for respiratory diseases, as the journal increasingly prioritizes studies on newer therapeutic options and combination therapies.

Similar Journals

RESPIRATORY MEDICINE

Innovating Solutions for Respiratory Challenges
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Annals of Thoracic Medicine

Elevating patient care through groundbreaking research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Multidisciplinary Respiratory Medicine

Unlocking the potential of respiratory research for global impact.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Lancet Respiratory Medicine

Empowering healthcare through exceptional respiratory research.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.

BMC Pulmonary Medicine

Advancing respiratory health through open access research.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

Indian Journal of Respiratory Care

Advancing Respiratory Health Through Open Access Research
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

Journal of Thoracic Disease

Shaping the future of respiratory disease management.
Publisher: AME PUBLISHING COMPANYISSN: 2072-1439Frequency: 12 issues/year

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

Pulmonology

Advancing lung health through groundbreaking research.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

RESPIRATION

Bridging Research and Clinical Practice for Better Outcomes
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Jornal Brasileiro de Pneumologia

Transforming respiratory medicine with groundbreaking discoveries.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.